|
|
|
|
Research Article
|
|
Advances in the Research of AMPK and its Subunit Genes
|
|
W.Y. Liu
and
R.S. Jiang
|
|
|
ABSTRACT
|
AMP-activated kinase (AMPK) is a heterotrimeric complex composed
of three subunits and is the core energy sensor of the cell. The AMPK activity
is important for survival during periods of stress and starvation and also has
implications in type II diabetes, obesity, metabolic syndrome, longevity and
cancer, etc. The activation of AMPK is triggered through binding of Adenosine
Monophosphate Activated Proteins (AMP) to the Bateman domains of the gamma subunit,
leading to increased phosphorylation of the threonine 172 on the alpha subunit
by inducing allosteric activation and inhibiting dephosphorylation. AMPK and
its subunits have been the focuses of many researchers dealing with genetic
and metabolic issues. The study makes a comprehensive review on the structure,
function, distribution, enzyme activity, the genetic mutation and other aspects
of AMPK and its subunit genes, with the aim to outline main aspects of present
researches on AMPK and its subunits in animal genetics.
|
|
|
|
|
Received: January 13, 2013;
Accepted: March 06, 2013;
Published: May 08, 2013
|
|
INTRODUCTION
It has been over forty years since when first identified and reported the kinase
HMG2CoA (Hardie et al., 1998; Ferrer
et al., 1985). The following researchers found that this kinase could
be easily activated by AMP and called it AMP-activated protein kinase (AMPK)
(Natsuume-Sakai et al., 1978; Kemp
et al., 1999). However, AMPK is mainly activated by an elevation
of intracellular 5-AMP with arsenite and heat shock in stress responses
(Corton et al., 1994). It is now regarded as
a key energy sensor or switch in cellular metabolism regulation responding to
stress signaling (Allard et al., 2007). Reports
on HMG-CoA reductase regulation also reinforced the concept of AMPK functioning
in metabolic stress responses (Sato et al., 1993).
When it is activated, the AMPK complex will switch on ATP-generating pathways
and switch off ATP-consuming pathways. This allows the cellular energy balance
to be restored (Hardie et al., 2003).
AMPK belongs to the family of serine-threonine protein kinases and self-forms
a heterotrimeric complex. Usually, it consists of a catalytic subunit (alpha)
and two non-catalytic subunits (beta and gamma) (Mitchelhill
et al., 1994; Carling et al., 1994;
Stapleton et al., 1994). Co-expression of the
non-catalytic beta and gamma subunits is demanded for the optimal activity of
the alpha subunit (Dyck et al., 1996). AMPK phosphorylates
a number of enzymes involved in the lipid metabolism control, such as HMG-CoA
reductases, acetyl-CoA carboxylases and hormone sensitive lipases (Hardie,
1992). In mammals, two or three isoforms of each AMPK subunit are often
encoded by distinct genes and may be combined at least 12 different heterotrimers
whose expression patterns differ among various tissues (Sanders
et al., 2007; Stapleton et al., 1996,
1997; Thornton et al.,
1998). AMPK is certainly one of the well-known sensors perceiving changes
in cellular energy metabolism (Lizcano et al., 2004).
In response to metabolic stress depleting ATP, AMPK rapidly switches on catabolic
processes and switches off ATP-consuming metabolic pathways to provide some
ATP (Lage et al., 2008; Carling,
2004). It maintains the dynamic metabolism equilibriums between the cellular
energy supply and demand by affecting the metabolic links. It is well-known
that AMPK is activated by an increase in the cellular AMP: ATP ratio after ATP
depletion and the classic function of AMPK is to maintain energy homeostasis
in modulating metabolic pathways (Sanders et al.,
2007). However, recent studies have revealed an expanded role for the kinase
AMPK in regulating cell growth and proliferation, cell membrane polarity and
mitochondrial biogenesis, etc. (Steinberg and Kemp, 2009).
AMPK also plays a critical role in cellular responses to diverse physiologic
and pathologic stresses like diabetes and obesity. It emerges to be a potential
therapeutic target for treatment of diabetes, cancer and cardiovascular disease.
For instance, Adipocyte AMPK could be targeted to modulate obesity-related adipokine
production associated with clinical insulin resistance and breast cancer cell
proliferation (Joseph et al., 2011). The pharmacological
activation of AMPK by metformin has proven to be a beneficial therapeutic approach
for the treatment of type II diabetes and atherosclerosis. Therefore, AMPK and
its subunits have been the focuses of researchers dealing with genetic and metabolic
issues. The present work makes a comprehensive review on the research advances
and application aspects of AMPK and its subunit genes in animal genetics.
Structure and function of AMPK subunits: AMPK belongs to the serine-threonine
kinase superfamily existing extensively in eukaryotic cells. The AMPK complex
was a kind of hetero-triplicate protein composed of three subunits, namely alpha,
beta and gamma. Among these subunits, alpha functions as the catalytic subunit,
beta and gamma serves as the regulatory subunits. Moreover, many sub-types of
subunits were found to be encoded by distinct genes, such as alpha 1 and alpha
2, beta 1 and beta 2, gamma 1, gamma 2 and gamma 3.
In the enzyme composition, alpha subunit is the kinase catalytic site responsible
for the ATP phosphoric acid base group to be passed to target proteins. It contains
two main functional ends or areas (i.e. N and C) and alpha subunit might combine
with the beta and/or gamma subunits at the C terminal region. The N end is the
core catalytic part of alpha subunit, while the C end is the allosteric part
responsible for the combination and activity regulation of AMP (Hudson
et al., 2003). The N end of beta subunit was followed by two conservative
domains, i.e. KIS and ASC and the KIS domain was a functional glycogen-binding
domain (Hudson et al., 2003), but the ASC domain
was incapable to form stable and active complex tripolymers (Polekhina
et al., 2003). In the gamma subunit, there are four serial duplicate
cystathionine b-synthase (CBS) domains responsible for the protein connection
of AMPK with AMP, while the beta subunit acts as a scaffold and brackets the
alpha, gamma subunits with its anchoring domains of KIS and ASC, respectively
(Winder and Thomson, 2007). AMPK would be activated
via phosphorylatio when the AMPKK (AMP-activated protein kinase kinase) was
revitalized. The detailed binding site is the first 172 threonine in the AMPK
alpha subunit. Reports showed that the alpha 1 subunit was located in the cytoplast
and the alpha 2 subunit was positioned in the karyon (Dyck
et al., 1996). These results suggested that the AMPK alpha 2 complex
might regulate nuclear gene expression with phosphorylated nuclear transcription
factors.
In mammalian cells, the catalytic alpha subunit of AMPK has no activity because
of its self-inhibition region, e.g. the 313-392 amino acid residues in alpha
1 subunit, but the subunit inhibitory mechanism is not reported and clearly
defined. By means of molecular biology technology, such as gene deletion or
missing, site-directed mutation, structural simulation and RNAi experiments,
it was found that a conservative residual fragment of the 313335 residues
in the alpha helix was crucial to keep the self-inhibition activity of alpha
1 subunit (Chen et al., 2009). It was further
pointed out that the inner Leu-328 and the outer Val-298 residues of the self-restraint
activity region could stabilize the self-inhibition active conformation through
hydrophobic interactions in human and animal carcinoma cells (Jin
et al., 2007; Chen et al., 2009).
AMPK heterotrimeric complex: AMPK is present in all tissues as a heterotrimeric
complex consisting of a catalytic alpha subunit and the regulatory beta and
gamma subunits (Xiao et al., 2007; Witczak
et al., 2008). Both beta and gamma subunits are required for the
optimal activity of alpha-catalytic subunit (Chen et
al., 1999). Multiple genes exist for each of the subunits (alpha1, alpha2,
beta1, beta2, gamma1, gamma2, gamma3), enabling the expression of less than
12 heterotrimer combinations which are expressed in tissue-specific manners
(Mahlapuu et al., 2004). In addition, alternative
splice variants exist for alpha1 and gamma2 which further increases the potential
diversity of the AMPK heterotrimers. In human skeletal muscle, the majority
of AMPK complexes contain both alpha2 and beta2 subunits. Among these alpha2/beta2
complexes, 20% associate with gamma3 and the remaining alpha1/beta2 and alpha2/beta2
associate with gamma1 (Wojtaszewski et al., 2005).
In mice skeletal muscle, gamma3- and gamma2 AMPK is mainly expressed in the
fast-twitch glycolytic Extensor Digitroum Longus (EDL) muscle compared to the
slow-twitch oxidative soleus muscle (Barnes et al.,
2004; Mahlapuu et al., 2004), whereas in
gastrocnemius muscle, gamma1, gamma2 and gamma3 are evenly expressed (Barnes
et al., 2004; Mahlapuu et al., 2004).
Tissue-specific expression of AMPK subunit genes: The distribution of
AMPK subunits varies and their expressions were reported tissue-specific. There
are two kinds of alpha and beta subunit isomers in skeletal muscle tissues,
namely alpha 1 and alpha 2 and beta 1 and beta 2, but the gamma subunits differentiate
into three isomers. Alpha 1 subunit highly exists in kidneys, liver, lungs,
heart and brain, while alpha 2 subunit dominates ~80% of all the AMPK trimers
and is more likely distributed in skeletal muscle tissues, heart and liver.
Beta 1 subunit shows high expression and mainly lied in the liver, while Beta
2 subunit is primarily found in the skeletal muscle. Gamma 1 and gamma 2 subunits
are also widely distributed, while gamma 3 subunit appears specifically in skeletal
muscle tissues. Among mouse, rat, cattle, goat and human tissues, the gamma
subunits of AMPK showed a sequence homology and/or genetic conservative property
measured with cDNA and amino acid fragment (Stapleton et
al., 1997). In fact, there were more than 12 different combinations
of AMPK subunits and different cellular types of the AMPK compound were found.
It is more likely to be involved the selection of downstream target proteins.
In mammals, the AMPK heterotrimers developed into a protein complex and mainly
expressed in a tissue-specific manner. At present, although the literatures
provided the primary information on the distribution and structure and biochemical
characteristics of various heterotrimers, the functional and biological significances
of this diversity were not clear. Moreover, there are few studies investigating
the heterotrimer distributions of AMPK complexity in human and animal skeletal
muscle tissues (Treebak et al., 2009; Birk
and Wojtaszewski, 2006; Wojtaszewski et al.,
2005). However, together with mutation and knock-out models, these data
gave us some important research clues to the diverse biological functions of
AMPK complexity in different types of cells and tissues. Among the subunit isomers,
the gamma 3 isoform is of particular interest because its very selectively
expressed in white skeletal muscle tissues (Mahlapuu et
al., 2004; Barnes et al., 2004; Yu
et al., 2004). Furthermore, the gamma 3 isoform makes up the only
human heterotrimer being activated with high intensity exercise (Birk
and Wojtaszewski, 2006; Treebak et al., 2007)
and the expression level of gamma3 protein differs with training status, age
and sex (Frosig et al., 2004; Mortensen
et al., 2009; Wojtaszewski et al., 2005).
Besides the tissue specific expression manner, the gamma 3 isoform is also selectively
distributed in complex partners who was only found being presented in complex
with alpha2 and beta2 in white mouse muscle Extensor Digitorum Longus (EDL)
and at very low levels in the red soleus muscle (Treebak
et al., 2009). Although all the seven subunits are widely expressed
in human and animal skeletal muscle, coimmuno-precipitation analyses reveal
that only three complexes seem to exist in human vastus lateralis muscle tissues,
i.e. alpha2-beta2-gamma1 (65%), alpha1-beta2-gamma1 (15%) and alpha2-beta2-gamma3
(20%) (Birk and Wojtaszewski, 2006; Wojtaszewski
et al., 2005). This distribution of AMPK complexes is very similar
to expression manner in the mouse EDL muscle tissues (Treebak
et al., 2009).
Regulation of AMPK activity: AMPK is got activated by alterations of
the AMP: ATP ratios in response to energetic stress and requires the phosphorylation
of site Thr172 in the catalytic subunits activation loop (Hardie
et al., 1999). Once activated, AMPK will induce ATP-generating catabolic
pathways including glucose metabolism and fatty acid oxidation and at the same
time inhibit ATP consuming anabolic pathways including cholesterol, fatty acid
and triacylglycerol synthesis (Hardie et al., 1999,
2003; Hardie., 2007). The AMPK
complex activity is regulated by nutrients (mainly glucose and amino acids)
(Leclerc and Rutter, 2004; Bungo
et al., 2011), hormones, calcium and metformin (Doustar
et al., 2012) and cellular stress etc. AMPK coordinates these signals
via phosphorylation of numerous targets involved in glucose uptake and its subsequent
utilization by tissues, ATP-generating and consumption, such as fatty acid oxidation
and protein synthesis (Xue and Kahn, 2006).
Presently, three upstream kinases have been identified as activators of AMPK,
i.e. the tumor suppressor LKB1, calcium/calmodulin-dependent protein kinase
(CaMKK) and TGF-beta-activated kinase-1 (TAK1) (Hong et
al., 2003, 2005; Momcilovic
et al., 2006). Generally speaking, the AMPK complex activity is regulated
at the level of allosteric activation by adenine nucleotides and of direct phosphorylation
by upstream activating kinases, including LKB1, CAMKK2 and TAK1, etc. (Lizcano
et al., 2004; Hawley et al., 2003;
Woods et al., 2003). Reversible phosphorylation
at site Thr172 within the activation loop of alpha subunit is the mainly activator
of AMPK (Oliveira et al., 2012). Besides phosphorylation,
AMPK can also be directly activated by AMP and ADP that bind to the gamma subunit,
which is important for maintaining AMPK activity (Sanders
et al., 2007; Oakhill et al., 2011;
Xiao et al., 2011). The binding of AMP and ADP
to the gamma subunit was thought to induce a conformational change in the kinase
domain which protects the AMPK Thr172 site from dephosphorylation by protein
phosphatase 2 A and C (PP2A and C) (Sanders et al.,
2007; Oakhill et al., 2011). The other two
upstream kinases, LKB1 and Ca2+/CaM-dependent protein kinase kinase (CaMKK),
have been shown to phosphorylate AMPK Thr172 site in mammalian cells too (Hawley
et al., 2003; Woods et al., 2003).
LKB1 is also a heterotrimer complex with regulatory proteins STRAD and MO25.
The LKB1 tumor suppressor kinase is an activator of AMPK. Recent studies reported
that LKB1 and AMPK controlled the cellular polarity and inhibited the breast
carcinogenesis from invertebrates to mammals (Nagalingam
et al., 2012). Taken from literatures, LKB1 and AMPK are regarded
as two key components of an epithelial polarity pathway, i.e. the LKB1-AMPK
pathway. This molecular complex link between polarity and metabolism may constitute
an ancient stress-response protective mechanism that was co-opted for tumor
suppression. Unfortunately, there are presently only few reports.
AMPK and obesity inducing and fatty acid uptaking: AMPK was reported
activated in response to metabolic stresses such as muscle contraction or hypoxia
and modulated by hormones and cytokines that affect whole-body energy balance,
such as leptin, adiponectin, resistin and ghrelin (Hardie,
2003; Hardie et al., 2003). Tissue or cellular
high ATP content, a reflection of high cellular energy status, will antagonize
the binding of AMP to the gamma subunit and this allows the AMPK modulating
system to act as a sensor of cellular energy status (Hardie,
2008). Therefore, AMPK was first discovered as a sensor of cellular energy
status in eukaryotic cells. AMPK, this fuel-sensing enzyme, is often activated
by phosphorylation when a cellular stress increases the AMP: ATP ratio due to
increased ATP depletion (muscle contraction) or limited generation of ATP (e.g.
hypoxia). Consequently, AMP production (e.g. exercise). Activation of AMPK usually
leads to the concomitant inhibition of energy-consuming biosynthetic pathways
not required for survival and to the activation of metabolic pathways regenerating
ATP (Richter and Ruderman, 2009).
The role of AMPK in mediating energy metabolism is mainly controlled by two
upstream kinases, i.e. LKB1 and/or CaMKK kinase b (CaMKKb) in response to baicalin
(Ma et al., 2012). Now, there are some new evidences
for the role of AMPK in fatty acid assimilating or steroid hormone biosynthesis
in starvation conditions. Generally speaking, starvation induces stress and
the following energy deprivation to maintain proper cell functions. Hirsch
et al. (2012) showed that starvation growth conditions shift steroidogenesis
of human adrenal NCI-H295R cells towards the androgen production attributable
to decreased HSD3B2 expression and activity and increased CYP17A1 phosphorylation
and 17,20-lyase activity. They concluded that starvation-mediated increase of
androgen production in NCI-H295 cells seem not to be mediated by AMPK signaling.
However, the AMPK activation could enhance androgen production through a specific
increase in CYP17A1-17,20 lyase activity (Hirsch et al.,
(2012). So far, many increased rates of long-Chain Fatty Acid (LCFA) uptaking
have been observed in skeletal muscle tissues of obese individuals (Bonen
et al., 2004; Yavari, 2008), as well as obese
(Shamsadin et al., 2001; Coort
et al., 2004; Han et al., 2007; Holloway
et al., 2009) and diabetic in Zucker rats (Smith
et al., 2007; Bonen et al., 2009).
This provides a plausible mechanism accounting for the intramuscular lipotoxic
environment implicated in peripheral muscle and insulin resistance in addition
to elevated levels of circulating plasma free fatty acids (Boden,
2003). Fortunately, three types of transport proteins have been identified
now, i.e. a protein of 40 kDa peripheral FABPPM located on the outer leaflet
of the plasma membrane (Stremmel et al., 1985;
Schwieterman et al., 1988; Isola
et al., 1995), fatty acid transport proteins of 63 kDa (FATP1-6)
with at least six trans-membrane domains (Schaffer and Lodish,
1994; Hirsch et al., 1998; Gimeno
et al., 2003) and a highly glycosolated protein of 88 kDa (FAT/CD36)
with at least two transmembrane domains (Abumrad et al.,
1993). Though research has shown a role for FATP1 and four in LCFA transport
(Kim et al., 2004; DiRusso
et al., 2005), less is known about the regulation of the FATP protein
family in response to physiological stimuli, obesity and insulin resistance,
etc. Therefore, AMPK may be important for regulation of fatty acid uptake in
response to pharmacological agents, the AMPK independent pathways are required
for regulating this process during exercise.
AMPK gene mutations in animal genetics researches: AMPK (AMP-activated
Kinase) is activated by changes in the intracellular AMP: ATP ratio when ATP
consumption is stimulated by contractile activity and AICAR and metformin compounds
that increase glucose transport in mammalian muscle cells. AMPK is invariably
regarded as the master metabolic switch and mediates the observed increase of
glucose uptake in mammal locomotory muscle during exercising. Therefore, researchers
have widely investigated the possible role of AMPK in the regulation of glucose
metabolism and its association with meat quality in skeletal muscle tissues
of some vertebrates, including human, goat, cattle, mouse, rat, chicken and
fish (Irrcher et al., 2008; Beck
Jorgensen et al., 20009; Magnoni et al.,
2012; Wilson et al., 2012).
The genetic mutations and effects of AMPK and its subunits have been the research
focuses of disease resistant and meat quality regulation in domestic animal
genetics too. Different from ordinary candidate genes of reproducing characters,
such as the pituitary specific transcription factor POU1F1 (Jiang
et al., 2004), prolactin and prolactin receptor genes (Jiang
et al., 2005, 2009; Jiang
and Geng, 2011), parathyroid hormone genes (Jiang
et al., 2010) and the β2-Adrenergic Receptor (Han
et al., 2011) and Alkaline Phosphatase loci (Orunmuyi
et al., 2007), at present, there was little gene polymorphism found
of AMPK subunit genes in domestic animals and fowls due to the complicated cases
of energy balance and its molecular linking network (Arain
et al., 2010a, b; Jafarnejad
and Sadegh, 2011; Afolayan et al., 2012).
However, the AMP-activated protein kinase gamma subunit was frequently referred.
Meat quality traits are always the hotspots to researchers in domestic animal
genetics (Malkawi and Gharaibeh, 2004; Das
et al., 2007; Ganabadi et al., 2009;
Arain et al., 2010a, b;
Wongsuthavas et al., 2011; Jafarnejad
and Sadegh, 2011; Joseph et al., 2011; Olajide
2012; Hossain et al., 2012). Since Lief
andesson and his coworkers identified and characterized the AMPK gamma 3 mutations
associated with excess glycogen content in pig skeletal muscle (Milan
et al., 2000; Andersson, 2003), it has been
a hotspot topic to find out gene mutations of AMPK subunits and its association
with meat quality in domestic animals (Andersson, 2001,
2009; Andersson and Georges, 2004).
There were many interesting reports in pig (Ciobanu et
al., 2001; Roux et al., 2006), chicken
(Zhao et al., 2006; Bungo
et al., 2011), cattle (Granlund et al.,
2011) and goats (Jin et al., 2012) and other
animals. Our group has also been on the way of researching the gene mutational
effects on meat quality in domestic animals and fowls. For instance, Zhao
et al. (2006) surveyed and reported the relevance of single-nucleotide
polymorphisms in the 5 end and exons of the PRKAG3 (AMPK gamma 3) gene
loci in two commercial and three Chinese indigenous chicken breeds. In this
study, two single-nucleotide polymorphisms (SNPs) in the 5-end of PRKAG3
gene and 10 SNPs in exons 3, 4, 9 and 11 in the PRKAG3 gene were identified
among the five chicken breeds and the result showed a significant association
between the mutations of PRKAG3 and chicken meat quality. Jin
et al. (2012) made an analysis of PRKAG3 gene variation and its association
with carcass quality of goat breeds. They investigated the polymorphism of goat
PRKAG3 gene and its distribution patterns in different goat breeds. They found
that two mutation loci in the 5 regulatory region, C-525A and C-225T,
located at -525 and -225 bp upstream of the start codon of the PRKAG3 gene and
two mutation loci in the exon 13, T90C and C102T, located at 90 bp and 102 bp
of the exon 13. They concluded with statistics that the lipoidosis ability of
goat breeds may be associated with C-525A and C-225T loci of PRKAG3 gene. Chen
et al. (2012) analyzed the polymorphisms of Goat THRSP gene in Chinese
indigenous goat breeds to identify polymorphism loci of goat THRSP gene associated
with the goat lipogenesis ability and ecological factors. Recently, we designed
primers for the PCR reactions of AMPK subunit gamma isoform genes, PRKAG1, PRKAG2
and PRKAG3, among different chicken lines, followed with single-nucleotide polymorphism
analysis. There are many point mutations identified, including one insert and
three mis-sense mutations. With correlation analysis, we found these mutations
were significant relevant to the carcass quality traits among chicken lines
(unpublished data). Moreover, Li (2007) showed many meaningful
results from studies on genetic polymorphisms in mice and Japanese rabbits and
gene differentially expressing experiments in corresponding skeletal muscle
and fat tissues. For instance, there was a 1944 site G→A mutation in mice
AMPK alpha 2 (PRKAA2) gene loci, but the mutation was synonymous so that no
effect on the increase or loss of fat and muscle and body weight detected (Li,
2007). However, there was a non-synonymous mutation between the Japan's
great ear and the wild populations. It was an inserting mutation at the 8731
site in the ninth exon of AMPK alpha 2 (PRKAA2) gene loci, which was significant
related with the changes of rabbit fat and muscle and weight. Another mutation
of PRKAG 2 gene loci is at the 3429 site inserted with A resulting a terminating
codon and the protein sequence composed of 1143 amino acid residues, but it
was statistically uncorrelated with fat and muscle and body weight loss (Li,
2007). Moreover, there was a point mutation (A→ G) at the 1754 site
in the fourth exon of AMPK alpha 1 (PRKAA1) gene loci between the Japan's great
ear rabbit and the wild groups, resulting a shorten protein encoded with a Lys
→ Arg change at sequence site 585 (Li, 2007). This
mutation resulted many carcass performances differences of intramuscular fat
content, live weight and eviscerated yield. In addition, there was an inserting
mutation at the 1531 site with C in the AMPK gamma 1 (PPKAG 1) gene loci between
the Japan's great ear rabbit and the wild groups and no difference of similar
growth and carcass performances was reported or found among the homozygous mutations
or genotypes (Li, 2007). Up to day, the AMPK alpha 2
gene loci is properly a good choice whose genetic SNP can be used as fat markers
in animal genetic selecting and breeding, while the usage of SNP polymorphisms
of AMPK Alpha 1 gene loci should be further explored. Researchers (Xiao
et al., 2007; Witczak et al., 2008)
also found that the missense mutation of human PRKAG2 gene loci encoding AMPK
gamma 2 subunit was involved in the pathogenesis of familial preexcitation syndrome.
This mutant changed the amino acid residue at the 302 site in gamma 2 subunit
from arginine to glutamic acid. This result was also observed in the site-directed
mutagenesis experiment of AMPK gamma 2 subunit (PRKAG2) gene fragments (Sanders
et al., 2007; Kilimann et al., 2005).
However, there are currently not enough polymorphism data of AMPK gamma subunit
gene and other gene loci for future animal genetics researches.
CONCLUSION
The importance of AMPK and its subunits in regulating fatty acid metabolism
and genetic effect of mutation has been highlighted in this review. Given that
disturbances in the metabolic pathways contribute to variations of fat and muscle
and daily gain during animal growth and development, it is critical to survey
and understand the underlying mechanisms, detect and exploit novel mutations
or single nucleotide polymorphism s, in order to develop new strategies for
genetically improving animal products and serve for molecular breeding. AMPK
subunit genes could be good genetic markers in animal genetics researches. Further
efforts supporting this idea are needed to be future investigated.
ACKNOWLEDGMENTS
We are grateful to the anonymous reviewers for their criticisms and suggestions.
This work was supported by Anhui Provincial Natural Science Foundation (Grant
No.1308085QC63) and the Key Project of Anhui Provincial Natural Science Foundation
for Colleges and Universities (Grant No. KJ2012A216) to prof Dr. Liu, WY.
|
REFERENCES |
1: Yavari, A., 2008. Mechanisms of exercise-induced glucose uptake: Evidences and hypothesises. Res. J. Biol. Sci., 3: 1208-1217. Direct Link |
2: Abumrad, N.A., M.R. El-Maghrabi, E.Z. Amri, E. Lopez and P.A. Grimaldi, 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem., 268: 17665-17668. Direct Link |
3: Allard, M.F., H.L. Parsons, R. Saeedi, R.B. Wambolt and R. Brownsey, 2007. AMPK and metabolic adaptation by the heart to pressure overload. Am. J. Physiol. Heart Circ. Physiol., 292: H140-H148. CrossRef | Direct Link |
4: Andersson, L., 2001. Genetic dissection of phenotypic diversity in farm animals. Nat. Rev. Genet., 2: 130-138. CrossRef | PubMed | Direct Link |
5: Andersson, L. and M. Georges, 2004. Domestic-animal genomics: Deciphering the genetics of complex traits. Nat. Rev. Genet., 5: 202-212. Direct Link |
6: Andersson, L., 2003. Identification and characterization of AMPK gamma 3 mutations in the pig. Biochem. Soc. Trans., 31: 232-235. Direct Link |
7: Andersson, L., 2009. Genome-wide association analysis in domestic animals: A powerful approach for genetic dissection of trait loci. Genetica, 136: 341-349. CrossRef |
8: Barnes, B.R., S. Marklund, T.L. Steiler, M. Walter and G. Hjalm et al., 2004. The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem., 279: 38441-38447. Direct Link |
9: Beck Jorgensen, S., H.M. O'Neill, K. Hewitt, B.E. Kemp and G.R. Steinberg, 2009. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia, 52: 2395-2404. CrossRef | PubMed | Direct Link |
10: Birk, J.B. and J.F. Wojtaszewski, 2006. Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle. J. Physiol., 577: 1021-1032. Direct Link |
11: Boden, G., 2003. Effects of free fatty acids on gluconeogenesis and glycogenolysis. Life Sci., 72: 977-988.
12: Bonen, A., M.L. Parolin, G.R. Steinberg, J. Calles-Escandon and N.N. Tandon et al., 2004. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J., 18: 1144-1146. Direct Link |
13: Bonen, A., G.P. Holloway, N.N. Tandon, X.X. Han, J. McFarlan, J.F. Glatz and J.J. Luiken, 2009. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 297: R1202-R1212. Direct Link |
14: Carling, D., 2004. The AMP-activated protein kinase cascade a unifying system for energy control. Trends Biochem. Sci., 29: 18-24. CrossRef |
15: Carling, D., K. Aguan, A. Woods, A.J. Verhoeven and R.K. Beri et al., 1994. Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J. Biol. Chem., 269: 11442-11448. Direct Link |
16: Ciobanu, D., J. Bastiaansen, M. Malek, J. Helm, J. Woollard, G. Plastow and M. Rothschild, 2001. Evidence for new alleles in the protein kinase adenosine monophosphate-activated {gamma}3-subunit gene associated with low glycogen content in pig skeletal muscle and improved meat quality. Genetics, 159: 1151-1162. PubMed | Direct Link |
17: Chen, L., Z.H. Jiao, L.S. Zheng, Y.Y. Zhang, S.T. Xie, Z.X. Wang and J.W. Wu, 2009. Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature, 459: 1146-1149. CrossRef | Direct Link |
18: Chen, Z., J. Heierhorst, R.J. Mann, K.I. Mitchelhill and B.J. Michell et al., 1999. Stapleton expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. FEBS Lett., 460: 343-348. Direct Link |
19: Coort, S.L., D.M. Hasselbaink, D.P. Koonen, J. Willems and W.A. Coumans et al., 2004. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes, 53: 1655-1663. Direct Link |
20: Corton, J.M., J.G. Gillespie and D.G. Hardie, 1994. Role of the AMP-activated protein kinase in the cellular stress response. Curr. Biol., 4: 315-324. Direct Link |
21: DiRusso, C.C., H. Li, D. Darwis, P.A. Watkins, J. Berger and P.N. Black, 2005. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J. Biol. Chem., 280: 16829-16837. Direct Link |
22: Dyck, J.R., G. Gao, J. Widmer, D. Stapleton, C.S. Fernandez, B.E. Kemp and L.A. Witters, 1996. Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic β and γ subunits. J. Biol. Chem., 271: 17798-17803. Direct Link |
23: Ferrer, A., C. Caelles, N. Massot and F.G. Hegardt, 1985. Activation of rat liver cytosolic 3-hydroxy-3-methylglutaryl coenzyme A reductase kinase by adenosine 5'-monophosphate. Biochem. Biophys. Res. Commun., 132: 497-504. CrossRef | PubMed | Direct Link |
24: Frosig, C., S.B. Jorgensen, D.G. Hardie, E.A. Richter and J.F. Wojtaszewski, 2004. 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 286: E411-E417. Direct Link |
25: Gimeno, R.E., A.M. Ortegon, S. Patel, S. Punreddy and P. Ge et al., 2003. Characterization of a heart-specific fatty acid transport protein. J. Biol. Chem., 278: 16039-16044. Direct Link |
26: Granlund, A., M. Jensen-Waern and B. Essen-Gustavsson, 2011. The influence of the PRKAG3 mutation on glycogen, enzyme activities and fibre types in different skeletal muscles of exercise trained pigs. Acta Vet. Scand., Vol. 53. 10.1186/1751-0147-53-20
27: Han, X.X., A. Chabowski, N.N. Tandon, J. Calles-Escandon, J.F.C. Glatz, J.J.F.P. Luiken and A. Bonen, 2007. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese zucker rat muscle. Am. J. Physiol. Endocrinol. Metab., 293: E566-E575. Direct Link |
28: Hardie, D.G., 1992. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim. Biophys. Acta, 1123: 231-238.
29: Hardie, D.G., D. Carling and M. Carlson, 1998. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell? Ann. Rev. Biochem., 67: 821-855. CrossRef | PubMed | Direct Link |
30: Hardie, D.G., J.W. Scott, D.A. Pan and E.R. Hudson, 2003. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett., 546: 113-120. CrossRef |
31: Hardie, D.G., 2003. Minireview: The AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology, 144: 5179-5183. PubMed | Direct Link |
32: Hardie, D.G., 2008. AMPK: A key regulator of energy balance in the single cell and the whole organism. Int. J. Obest., 32 Suppl: S7-S12. CrossRef | PubMed | Direct Link |
33: Hardie, D.G., I.P. Salt, S.A. Hawley and S.P. Davies, 1999. AMP-activated protein kinase: An ultrasensitive system for monitoring cellular energy charge. Biochem. J., 338: 717-722. Direct Link |
34: Hardie, D.G., 2007. AMP-activated protein kinase as a drug target. Annu. Rev. Pharmacol. Toxicol., 47: 185-210. CrossRef | Direct Link |
35: Hawley, S.A., J. Boudeau, J.L. Reid, K.J. Mustard and L. Udd et al., 2003. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol., Vol. 2. 10.1186/1475-4924-2-28
36: Hirsch, A., D. Hahn, P. Kempna, G. Hofer, P.E. Mullis, J.M. Nuoffer and C.E. Fluck, 2012. Role of AMP-activated protein kinase on steroid hormone biosynthesis in adrenal NCIH295R cells. PLoS One, Vol. 7. 10.1371/journal.pone.0030956
37: Hirsch, D., A. Stahl and H.F. Lodish, 1998. A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl Acad. Sci. USA., 95: 8625-8629. Direct Link |
38: Holloway, G.P., C.R. Benton, K.L. Mullen, Y. Yoshida and L.A. Snook et al., 2009. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am. J. Physiol. Endocrinol. Metab., 296: E738-E747. Direct Link |
39: Hong, S.P., F.C. Leiper, A. Woods, D. Carling and M. Carlson, 2003. Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc. Nat. Acad. Sci. USA., 100: 8839-8843. PubMed |
40: Hong, S.P., M. Momcilovic and M. Carlson, 2005. Function of mammalian LKB1 and Ca2+/calmodulin-dependent protein kinase kinase alpha as Snf1-activating kinases in yeast. J. Biol. Chem., 280: 21804-21809. Direct Link |
41: Hudson, E.R., D.A. Pan, J. James, J.M. Lucocq and S.A. Hawley et al., 2003. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol., 13: 861-866. CrossRef | Direct Link |
42: Isola, L.M., S.L. Zhou, C.L. Kiang, D.D. Stump, M.W. Bradbury and P.D. Berk, 1995. 3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty Acid-binding protein and saturable fatty acid uptake. Proc. Natl. Acad. Sci. USA, 92: 9866-9870. Direct Link |
43: Irrcher, I., V. Ljubicic, A.F. Kirwan and D.A. Hood, 2008. AMP-activated protein kinase-regulated activation of the PGC-1a promoter in skeletal muscle cells. PLoS One, Vol. 3. 10.1371/journal.pone.0003614
44: Jiang, R., J. Li, L. Qu, H. Li and N. Yang, 2004. A new single nucleotide polymorphism in the chicken pituitary-specific transcription factor (POU1F1) gene associated with growth rate. Anim. Genet., 35: 344-346. CrossRef | PubMed |
45: Jiang, R.S., G.Y. Xu, X.Q. Zhang and N. Yang, 2005. Association of polymorphisms for prolactin and prolactin receptor genes with broody traits in chickens. Poult. Sci., 84: 839-845. CrossRef | PubMed | Direct Link |
46: Jiang, R.S., L.L. Zhang, Z.Y. Geng, T. Yang and S.S. Zhang, 2009. Single nucleotide polymorphisms in the 5'-flanking region of the prolactin gene and the association with reproduction traits in geese: Short communication. S. Afr. J. Anim. Sci., 39: 83-87. Direct Link |
47: Jiang, R.S. and Z.Y. Geng, 2011. Expression of plasma prolactin and pituitary prolactin mRNA around the broody cycle in Wan-xi White goose. Turk. J. Vet. Anim. Sci., 35: 431-434. CrossRef |
48: Jiang, R.S., Z. Xie, X.Y. Chen and Z.Y. Geng, 2010. A single nucleotide polymorphism in the parathyroid hormone gene and effects on eggshell quality in chickens. Poult. Sci., 89: 2101-2105. CrossRef | PubMed | Direct Link |
49: Kemp. B.E., K.I. Mitchelhill, D. Stapleton, B.J. Mitchell, Z.P. Chen and L.A. Walters, 1999. Dealing with energy demand: The AMP-activated protein kinase. Trends Biochem. Sci., 24: 22-25. Direct Link |
50: Kilimann, M.W., F.K. van Landeghem, C. Buhrer, J.W. Scott, G.F. Cox et al., 2005. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am. J. Hum. Genet., 76: 1034-1049. Direct Link |
51: Kim, J.K., R.E. Gimeno, T. Higashimori, H.J. Kim and H. Choi et al., 2004. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J. Clin. Invest., 113: 756-763. PubMed |
52: Lage, R., C. C. Dieguez, A. Vidal-Puig and M. Lopez, 2008. AMPK: A metabolic gauge regulating whole-body energy homeostasis. Trends Mol. Med., 14: 539-549. CrossRef | PubMed | Direct Link |
53: Leclerc, I. and G.A. Rutter, 2004. AMP-activated protein kinase: A new beta-cell glucose sensor?: Regulation by amino acids and calcium ions. Diabetes, 53: S67-S74. CrossRef | PubMed | Direct Link |
54: Lizcano, J.M., O. Goransson, R. Toth, M. Deak, N.A. Morrice et al., 2004. Lkb1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J., 23: 833-843. CrossRef | Direct Link |
55: Li, N., 2007. Study on the genetic polymorphisms of AMPK detected in Japanese big eared rabbits and mice. Ph.D. Thesis, Yang Zhou University.
56: Mahlapuu, M., C. Johansson, K. Lindgren, G. Hjalm and B.R. Barnes et al., 2004. Expression profiling of the Gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 286: E194-E200. Direct Link |
57: Ma, Y., F. Yang, Y. Wang, Z. Du and D. Liu et al., 2012. CaMKKb Is Involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines. PLoS One Vol. 7. 10.1371/journal.pone.0047900
58: Milan, D., J.T. Jeon, C. Looft, V. Amarger and A. Robic et al., 2000. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science, 288: 1248-1251. CrossRef | PubMed | Direct Link |
59: Mitchelhill, K.I., D. Stapleton, G. Gao, C. House and B. Michell et al., 1994. Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem., 269: 2361-2364. Direct Link |
60: Momcilovic, M., S.P. Hong and M. Carlson, 2006. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J. Biol. Chem., 281: 25336-25343. Direct Link |
61: Magnoni, L.J., Y. Vraskou, A.P. Palstra and J.V. Planas, 2012. AMP-Activated protein kinase plays an important evolutionary conserved role in the regulation of glucose metabolism in fish skeletal muscle cells. PLoS One, Vol. 7. 10.1371/journal.pone.0031219
62: Mortensen, B., P. Poulsen, L. Wegner, K.L. Stender-Petersen and R. Ribel-Madsen et al., 2009. Genetic and metabolic effects on skeletal muscle AMPK in young and older twins. Am. J. Physiol Endocrinol. Metab., 297: E956-E964. CrossRef |
63: Nagalingam, A., J.L. Arbiser, M.Y. Bonner, N.K. Saxena and D. Sharma, 2012. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res., Vol. 2. 10.1186/bcr3128
64: Natsuume-Sakai, S., J.I. Hayakawa and M. Takahashi, 1978. Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17. J. Immunol., 121: 491-498. Direct Link |
65: Oakhill, J.S., R. Steel, Z.P. Chen, J.W. Scott, N. Ling, S. Tam and B.E. Kemp, 2011. AMPK is a direct adenylate Charge-regulated protein kinase. Science, 332: 1433-1435. CrossRef | Direct Link |
66: Oliveira, S.M., Y.H. Zhang, R.S. Solis, H. Isackson and M. Bellahcene et al., 2012. AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes. Circ. Res., 110: 1192-1201. Direct Link |
67: Polekhina, G., A. Gupta, B.J. Michell, B. van Denderen and S. Murthy et al., 2003. AMPK beta subunit targets metabolic stress sensing to glycogen. Curr. Biol., 13: 867-871.
68: Richter, E.A. and N.B. Ruderman, 2009. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem. J., 418: 261-275. CrossRef | PubMed | Direct Link |
69: Roux, M., A. Nizou, L. Forestier, A. Ouali, H. Leveziel and V. Amarger, 2006. Characterization of the bovine PRKAG3 gene: Structure, polymorphism and alternative transcripts. Mamm. Genome, 17: 83-92. CrossRef | PubMed |
70: Sanders, M.J., P.O. Grondin, B.D. Hegarty, M.A. Snowden and D. Carling, 2007. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J., 403: 139-148. CrossRef | PubMed | Direct Link |
71: Jin, X., R. Townley and L. Shapiro, 2007. Structural insight into AMPK regulation: ADP comes into play. Structure, 15: 1285-1295. CrossRef |
72: Shamsadin, R., K. Jantsan, I. Adham and W. Engel, 2001. Cloning, organisation, chromosomal localization and expression analysis of the mouse Prkag1 gene. Cytogenet. Cell. Genet., 92: 134-138. CrossRef |
73: Sato, R., J.L. Goldstein and M.S. Brown, 1993. Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc. Natl. Acad. Sci. USA., 90: 9261-9265. PubMed | Direct Link |
74: Schaffer, J.E. and H.F. Lodish, 1994. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell, 79: 427-436. PubMed |
75: Schwieterman, W., D. Sorrentino, B.J. Potter, J. Rand, C.L. Kiang, D. Stump and P.D. Berk, 1988. Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc. Natl. Acad. Sci. USA., 85: 359-363. Direct Link |
76: Smith, A.C., K.L. Mullen, K.A. Junkin, J. Nickerson, A. Chabowski, A. Bonen and D.J. Dyck, 2007. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am. J. Physiol. Endocrinol. Metab., 293: E172-E181. CrossRef | PubMed |
77: Stapleton, D., E. Woollatt, K.I. Mitchelhill, J.K. Nicholl and C.S. Fernandez et al., 1997. AMP-activated protein kinase isoenzyme family: Subunit structure and chromosomal location. FEBS Lett., 409: 452-456. CrossRef | PubMed | Direct Link |
78: Stapleton, D., K.I. Mitchelhill, G. Gao, J. Widmer and B.J. Michell et al., 1996. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem., 271: 611-614. CrossRef | PubMed | Direct Link |
79: Stapleton, D., G. Gao, B.J. Michell, J. Widmer and K. Mitchelhill et al., 1994. Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J. Biol. Chem., 269: 29343-29346. Direct Link |
80: Steinberg, G.R. and B.E. Kemp, 2009. AMPK in health and disease. Physiol. Rev., 89: 1025-1078. Direct Link |
81: Stremmel, W., G. Lotz, G. Strohmeyer and P.D. Berk, 1985. Identification, isolation and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J. Clin. Invest., 75: 1068-1076. CrossRef |
82: Bungo, T., J.I. Shiraishi and S.I. Kawakami, 2011. Feeding responses to central glutamatergic receptor agonist administrations in meat-type chicks. J. Anim. Vet. Adv., 10: 955-958. CrossRef | Direct Link |
83: Thornton, C., M.A. Snowden and D. Carling, 1998. Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle. J. Biol. Chem., 273: 12443-12450. CrossRef | PubMed | Direct Link |
84: Treebak, J.T., J.B. Birk, B.F. Hansen, G.S. Olsen and J.F. Wojtaszewski, 2009. A-769662 activates AMPK β1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle. Am. J. Physiol. Cell Physiol., 297: C1041-C1052. CrossRef | Direct Link |
85: Treebak, J.T., J.B. Birk, A.J. Rose, B. Kiens, E.A. Richter and J.F.P. Wojtaszewski, 2007. AS160 phosphorylation is associated with activation of α2β2γ1-but not α2β2γ3-AMPK trimeric complex in skeletal muscle during exercise in humans. Am. J. Physiol. Endocrinol. Metab., 292: E715-E722. CrossRef |
86: Wilson, G.J., C.J. Moulton, P.J. Garlick, T.G. Anthony and D.K. Layman, 2012. Post-meal responses of elongation factor 2 (eEF2) and adenosine monophosphate-activated protein kinase (AMPK) to leucine and carbohydrate supplements for regulating protein synthesis duration and energy homeostasis in rat skeletal muscle. Nutrients, 13: 1723-1739. CrossRef | PubMed | Direct Link |
87: Winder, W.W. and D.M. Thomson, 2007. Cellular energy sensing and signaling by AMP-activated protein kinase. Cell Biochem. Biophys., 47: 332-347. CrossRef | PubMed |
88: Witczak, C.A., C.G. Sharoff and L.J. Goodyear, 2008. AMP-activated protein kinase in skeletal muscle: From structure and localization to its role as a master regulator of cellular metabolism. Cell. Mol. Life Sci., 65: 3737-3755. CrossRef |
89: Wojtaszewski, J.F.P., J.B. Birk, C. Frosig, M. Holten, H. Pilegaard and F. Dela, 2005. 5'AMP activated protein kinase expression in human skeletal muscle: Effects of strength training and type 2 diabetes. J. Physiol., 564: 563-573. CrossRef |
90: Woods, A., S.R. Johnstone, K. Dickerson, F.C. Leiper and L.G. Fryer et al., 2003. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol., 13: 2004-2008. PubMed |
91: Xiao, B., R. Heath, P. Saiu, F.C. Leiper and P. Leone et al., 2007. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature, 449: 496-500. CrossRef | PubMed | Direct Link |
92: Xiao, B., M.J. Sanders, E. Underwood, R. Heath and F.V. Mayer et al., 2011. Structure of mammalian AMPK and its regulation by ADP. Nature, 472: 230-233. CrossRef | PubMed | Direct Link |
93: Xue, B. and B.B. Kahn, 2006. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J. Physiol., 574: 73-83. CrossRef |
94: Yu, H., N. Fujii, M.F. Hirshman, J.M. Pomerleau and L.J. Goodyear, 2004. Cloning and characterization of mouse 5'-AMP-activated protein kinase γ3 subunit. Am. J. Physiol. Cell Physiol., 286: C283-C292. CrossRef |
95: Doustar, Y., D. Mohajeri, A. Garjani, G. Mousavi and M.N. Ghramaleki, 2012. Protective effect of metformin on cardiomyocytes Ischemia-Reperfusion (IR) induced apoptosis in rats. J. Anim. Vet. Adv., 11: 108-112. CrossRef | Direct Link |
96: Zhao, C.J., C.F. Wang, X.M. Deng, Y. Gao and C.H. Wu, 2006. Identification of single-nucleotide polymorphisms in 5' end and exons of the PRKAG3 gene in Hubbard White broiler, Leghorn layer and three Chinese indigenous chicken breeds. J. Anim. Breed. Genet., 123: 349-352. CrossRef | PubMed | Direct Link |
97: Chen, H.Q., J. Qin, Y.J. Zhu, Z.T. Pan and Y.N. Xie et al., 2012. The polymorphisms of goat THRSP gene associated with ecological factors in Chinese indigenous goat breeds with different lipogenesis ability. Asian J. Aaim. Vet. Adv., 7: 802-811. CrossRef | Direct Link |
98: Jin, H., H.Q. Chen, J. Qin, Y.J. Zhu and H. Chen et al., 2012. The polymorphism in 5 regulatory region and exon 13 of PRKAG3 gene and its distribution pattern in different goat breeds. Asian J. Animal Vet. Adv., 7: 568-577. CrossRef | Direct Link |
99: Arain, M.A., M. Khaskheli, I.R. Rajput, S. Faraz, S. Rao, M. Umer and K. Devrajani, 2010. Effect of slaughtering age on chemical composition of goat meat. Pak. J. Nutr., 9: 404-408. CrossRef | Direct Link |
100: Arain, M.A., M. Khaskheli, I.R. Rajput, S. Rao and S. Faraz et al., 2010. Examination of physical properties of goat meat. Pak. J. Nutr., 9: 422-425. CrossRef | Direct Link |
101: Das, A.K., R.B. Sharma and N.P. Singh, 2007. Quality and storage stability of low acid goat meat pickle. Am. J. Food Technol., 2: 550-554. CrossRef | Direct Link |
102: Olajide, R., 2012. Growth performance, carcass, haematology and serum metabolites of broilers as affected by contents of anti-nutritional factors in soaked wild cocoyam (Colocasia esculenta (L.) Schott) corm-based diets. Asian J. Anim. Sci., 6: 23-32. CrossRef | Direct Link |
103: Ganabadi, S., S. Mutuviren, M.A. Hilmi, S.M.A. Babjee, H. Yaakub and S. Fakurazi, 2009. Carcass composition of jungle fowl in comparison with broilers and indigenous chicken. Asian J. Anim. Sci., 3: 13-17. CrossRef | Direct Link |
104: Orunmuyi, M., O.O. Oni, I.A. Adeyinka and O.E. Asiribo, 2007. Genetic parameter estimates for plasma alkaline phosphatase activity and reproductive traits in two strains of rhode island chickens. Asian J. Anim. Sci., 1: 76-81. CrossRef | Direct Link |
105: Jafarnejad, S. and M. Sadegh, 2011. The effects of different levels of dietary protein, energy and using fat on the performance of broiler chicks at the end of the third weeks. Asian J. Poult. Sci., 5: 35-40. CrossRef | Direct Link |
106: Afolayan, S.B., I.I. Dafwang, T.S.B. Tegbe and A. Sekoni, 2012. Response of broiler chickens fed on Maize-based diets substituted with graded levels of sweet potato meal. Asian J. Poult. Sci., 6: 15-22. CrossRef |
107: Han, B., H.L. Zhang, L. Zeng, B. Yang, R. Abula, X.L. Xu and Y. Chen, 2011. The Polymorphisms of β2-Adrenergic Receptor Gene on two Cattle Breeds in China Asian J. Anim. Vet. Adv., 6: 715-722. CrossRef |
108: Wongsuthavas, S., C. Yuangklang, K. Vasupen, J. Mitchaothai, A. Alhaidary, H.E. Mohamed and A.C. Beynen, 2011. Fatty acid metabolism in broiler chickens fed diets either rich in linoleic or α-linolenic acid. Asian J. Anim. Vet. Adv., 6: 282-289. CrossRef | Direct Link |
109: Joseph, B., P. Sankarganesh, B.T. Edwin, S.J. Raj and M.V. Jeevitha et al., 2011. Sustainable energy resources from chicken. Asian J. Applied Sci., 4: 355-361. CrossRef | Direct Link |
110: Hossain, M.A., A.F. Islam and P.A. Iji, 2012. Energy utilization and performance of broiler chickens raised on diets with vegetable proteins or conventional feeds. Asian J. Poult. Sci., 6: 117-128. CrossRef | Direct Link |
111: Malkawi, H.I. and R. Gharaibeh, 2004. Rapid and simultaneous identification of two Salmonella enterica serotypes, enteritidis and typhimurium from chicken and meat products by multiplex PCR. Biotechnology, 3: 44-48. CrossRef | Direct Link |
|
|
|
 |